Skip to main content

Mirtazapine Tablets, USP, 7.5 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810 NDC 13107-001-05

Drug Recall

Official source record

Recall number
D-0637-2020
Event ID
84336
Classification
Class I
Status
Terminated
Recalling company
AuroMedics Pharma LLC
Reason for recall
Labeling: Label Error on Declared Strength; cases labelled Mirtazapine 15mg tablets, 500-count bottles, contain 500-count bottles of Mirtazapine 15mg tablets labelled as Mirtazapine 7.5 mg tablets.
Report date
December 18, 2019
Recall initiation date
November 20, 2019
Termination date
February 21, 2024
Distribution pattern
Nationwide

Drug product identifiers

Manufacturer
Aurolife Pharma LLC
Brand name
MIRTAZAPINE
Generic name
MIRTAZAPINE
Substance name
MIRTAZAPINE
Product NDCs
13107-001; 13107-003; 13107-031; 13107-032
Package NDCs
13107-001-01; 13107-001-05; 13107-001-30; 13107-001-60; 13107-001-90; 13107-003-01; 13107-003-05; 13107-003-30; 13107-003-32; 13107-003-34; 13107-003-60; 13107-003-90; 13107-031-01; 13107-031-05; 13107-031-30; 13107-031-32; 13107-031-34; 13107-031-60; 13107-031-90; 13107-032-01; 13107-032-05; 13107-032-32; 13107-032-34; 13107-032-60; 13107-032-90
Route
ORAL

Where this information comes from

View FDA enforcement record -- the specific openFDA drug enforcement record this summary was built from.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for details.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class I mean?

A situation in which there is a reasonable probability that use of or exposure to a product will cause serious adverse health consequences or death.

Is this recall still active?

According to the FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this medication?

Do not start, stop, or change any medication based on this page. Follow the instructions published by the FDA and the recalling company (see the source links below), and talk to your pharmacist or physician if you have questions about a specific medication.

Where can I find more official information?

The source links below, published by the FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

Public Health Trace republishes official FDA drug recall information -- it is not affiliated with the FDA, does not verify or supplement what the source has published, and does not provide medical advice. Never start, stop, or change a medication based on this page. Always follow the guidance of your pharmacist or physician, and consult the official source links above for the most current information. Read the full medical disclaimer.